Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 23169439)

1.

Synthesis of a new pH-sensitive folate-doxorubicin conjugate and its antitumor activity in vitro.

Ye WL, Teng ZH, Liu DZ, Cui H, Liu M, Cheng Y, Yang TH, Mei QB, Zhou SY.

J Pharm Sci. 2013 Feb;102(2):530-40. doi: 10.1002/jps.23381. Epub 2012 Nov 20.

PMID:
23169439
2.

Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles.

Ye WL, Du JB, Zhang BL, Na R, Song YF, Mei QB, Zhao MG, Zhou SY.

PLoS One. 2014 May 14;9(5):e97358. doi: 10.1371/journal.pone.0097358. eCollection 2014.

3.

Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.

Yin JJ, Sharma S, Shumyak SP, Wang ZX, Zhou ZW, Zhang Y, Guo P, Li CZ, Kanwar JR, Yang T, Mohapatra SS, Liu W, Duan W, Wang JC, Li Q, Zhang X, Tan J, Jia L, Liang J, Wei MQ, Li X, Zhou SF.

PLoS One. 2013 May 2;8(5):e62289. doi: 10.1371/journal.pone.0062289. Print 2013.

4.

Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.

Chiu CC, Lin YT, Sun SL, Sung KH, Wang LF.

J Biomater Sci Polym Ed. 2011;22(11):1487-507. doi: 10.1163/092050610X512414. Epub 2010 Jul 12.

PMID:
20626956
5.

Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.

Cao W, Zhou J, Mann A, Wang Y, Zhu L.

Biomacromolecules. 2011 Jul 11;12(7):2697-707. doi: 10.1021/bm200487h. Epub 2011 Jun 9.

PMID:
21619062
6.

Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.

Zhang C, Zhao L, Dong Y, Zhang X, Lin J, Chen Z.

Eur J Pharm Biopharm. 2010 Sep;76(1):10-6. doi: 10.1016/j.ejpb.2010.05.005. Epub 2010 May 22.

PMID:
20472060
7.

Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.

Zhang H, Li F, Yi J, Gu C, Fan L, Qiao Y, Tao Y, Cheng C, Wu H.

Eur J Pharm Sci. 2011 Apr 18;42(5):517-26. doi: 10.1016/j.ejps.2011.02.006. Epub 2011 Feb 23.

PMID:
21352909
8.

Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.

Scomparin A, Salmaso S, Bersani S, Satchi-Fainaro R, Caliceti P.

Eur J Pharm Sci. 2011 Apr 18;42(5):547-58. doi: 10.1016/j.ejps.2011.02.012. Epub 2011 Mar 1.

PMID:
21371555
9.

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.

Nanotechnology. 2011 Nov 11;22(45):455102. doi: 10.1088/0957-4484/22/45/455102. Epub 2011 Oct 21.

PMID:
22019849
10.

Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.

Shen Z, Li Y, Kohama K, Oneill B, Bi J.

Pharmacol Res. 2011 Jan;63(1):51-8. doi: 10.1016/j.phrs.2010.10.012. Epub 2010 Oct 28.

PMID:
21035550
11.

Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.

Gao F, Li L, Liu T, Hao N, Liu H, Tan L, Li H, Huang X, Peng B, Yan C, Yang L, Wu X, Chen D, Tang F.

Nanoscale. 2012 Jun 7;4(11):3365-72. doi: 10.1039/c2nr12094a. Epub 2012 Apr 27.

PMID:
22538830
12.

Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.

Okamatsu A, Motoyama K, Onodera R, Higashi T, Koshigoe T, Shimada Y, Hattori K, Takeuchi T, Arima H.

Biomacromolecules. 2013 Dec 9;14(12):4420-8. doi: 10.1021/bm401340g. Epub 2013 Nov 21.

PMID:
24175976
13.

Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.

Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S.

Biomaterials. 2010 Jul;31(21):5634-42. doi: 10.1016/j.biomaterials.2010.03.066. Epub 2010 Apr 28.

PMID:
20430433
14.

Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.

Yang X, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Matson VZ, Steeber DA, Gong S.

ACS Nano. 2010 Nov 23;4(11):6805-17. doi: 10.1021/nn101670k. Epub 2010 Oct 19.

PMID:
20958084
15.

Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier.

Huang SJ, Sun SL, Feng TH, Sung KH, Lui WL, Wang LF.

Eur J Pharm Sci. 2009 Aug 12;38(1):64-73. doi: 10.1016/j.ejps.2009.06.002. Epub 2009 Jun 18.

PMID:
19540339
16.

Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.

Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S.

Biomaterials. 2009 Oct;30(30):6065-75. doi: 10.1016/j.biomaterials.2009.07.048. Epub 2009 Aug 12.

PMID:
19674777
17.

Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.

Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S.

Biomaterials. 2009 Oct;30(29):5757-66. doi: 10.1016/j.biomaterials.2009.07.020. Epub 2009 Jul 29.

PMID:
19643472
18.

pH-triggered intracellular release from actively targeting polymer micelles.

Guo X, Shi C, Wang J, Di S, Zhou S.

Biomaterials. 2013 Jun;34(18):4544-54. doi: 10.1016/j.biomaterials.2013.02.071. Epub 2013 Mar 16.

PMID:
23510854
19.

Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.

Wen S, Liu H, Cai H, Shen M, Shi X.

Adv Healthc Mater. 2013 Sep;2(9):1267-76. doi: 10.1002/adhm.201200389. Epub 2013 Feb 28.

PMID:
23447549
20.

In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin.

Huan M, Zhang B, Teng Z, Cui H, Wang J, Liu X, Xia H, Zhou S, Mei Q.

PLoS One. 2012;7(9):e44116. doi: 10.1371/journal.pone.0044116. Epub 2012 Sep 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk